<qa>  - Prior systemic treatment with an anti-PD-1, anti-PD-L1,- Prior systemic treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell costimulation or immune checkpoint pathways; 